Ionis Pharmaceuticals
IONS
IONS
308 hedge funds and large institutions have $5.2B invested in Ionis Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 88 increasing their positions, 89 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 281 → 308 (+27)
6% more call options, than puts
Call options by funds: $79M | Put options by funds: $74.5M
1% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 89
Holders
308
Holding in Top 10
7
Calls
$79M
Puts
$74.5M
Top Buyers
| 1 | +$139M | |
| 2 | +$58.6M | |
| 3 | +$41.5M | |
| 4 |
O
OppenheimerFunds
New York
|
+$25.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$16.8M |
Top Sellers
| 1 | -$76.5M | |
| 2 | -$38.8M | |
| 3 | -$29.6M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$25.8M |
| 5 |
Goldman Sachs
New York
|
-$17.6M |